In this Issue
IRDs, Uveitis, and the Future of Care
Medical Editors’ Page
By Allen C. Ho, MD; and Robert L. Avery, MD
By I-Van Ho, MBBS, PhD, FRANZCO; Gerald Liew, MBBS, PhD, FRANZCO; Rohan Merani, MBBS, FRANZCO; and Alex P. Hunyor, MBBS, FRANZCO
Keep these texts handy and you’ll always have a resource to reference.
By Thomas L. Jenkins, MD; Ravi R. Pandit, MD, MPH; and David Xu, MD
What can a clinician who is not an inherited retinal disease expert do for patients with these conditions? Start here.
By Daniel L. Chao, MD, PhD
A review of the different approaches to treating IRDs.
By Alessandro Iannaccone, MD, MS, FARVO
Looking back at the first year of the first ocular gene therapy.
By Aaron Nagiel, MD, PhD
Clinical research teams are working toward a treatment for Stargardt disease. How far have they come?
By Thomas A. Ciulla, MD, MBA
Many techniques have been described; choose the best one for the individual patient.
By Barbara Parolini, MD, and Michele Palmieri, MD
Uveitis treatments are evolving. Steven Yeh, MD, helps you keep track of what’s changing.
With Steven Yeh, MD
Exploring the diagnosis and appropriate workup for a patient presenting with sclerochoroidal calcification.
By Wendy Liu, MD, PhD; Patrick Oellers, MD; and Dean Eliott, MD
An uncommon site for disease progression led to atypical first signs and symptoms of thyroid cancer metastasis.
By Michael Weaver, MS; Nikhil Dhall, BS; Komal Desai, MD; and Heeral R. Shah, MD
CODING FOR RETINA
Identifying the diagnosis—not the procedure—is the first step when coding for retina surgeries.